These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2165009)
61. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease. Cowburn R; Hardy J; Roberts P; Briggs R Neurosci Lett; 1988 Mar; 86(1):109-13. PubMed ID: 2896322 [TBL] [Abstract][Full Text] [Related]
62. The cholinergic system in Alzheimer's disease. Kása P; Rakonczay Z; Gulya K Prog Neurobiol; 1997 Aug; 52(6):511-35. PubMed ID: 9316159 [TBL] [Abstract][Full Text] [Related]
63. High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy. Bissette G; Seidler FJ; Nemeroff CB; Slotkin TA Ann N Y Acad Sci; 1996 Jan; 777():197-204. PubMed ID: 8624084 [TBL] [Abstract][Full Text] [Related]
64. The 12th J. A. F. Stevenson memorial lecture. Aging, Alzheimer's disease, and the cholinergic system. McGeer PL Can J Physiol Pharmacol; 1984 Jul; 62(7):741-54. PubMed ID: 6149804 [TBL] [Abstract][Full Text] [Related]
65. The place of choline acetyltransferase activity measurement in the "cholinergic hypothesis" of neurodegenerative diseases. Contestabile A; Ciani E; Contestabile A Neurochem Res; 2008 Feb; 33(2):318-27. PubMed ID: 17940885 [TBL] [Abstract][Full Text] [Related]
66. Glutamate transmission and toxicity in Alzheimer's disease. Greenamyre JT; Maragos WF; Albin RL; Penney JB; Young AB Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):421-30. PubMed ID: 2900537 [TBL] [Abstract][Full Text] [Related]
67. Do raised brain aluminium levels in Alzheimer's dementia contribute to cholinergic neuronal deficits? King RG Med Hypotheses; 1984 Jul; 14(3):301-6. PubMed ID: 6472159 [TBL] [Abstract][Full Text] [Related]
68. Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease? Lawlor BA; Davis KL Biol Psychiatry; 1992 Feb; 31(4):337-50. PubMed ID: 1348429 [TBL] [Abstract][Full Text] [Related]
69. Selectivity of excitotoxic mechanisms in Alzheimer's disease. May PC Neurobiol Aging; 1989; 10(5):606-8; discussion 618-20. PubMed ID: 2572984 [TBL] [Abstract][Full Text] [Related]
70. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Lowe SL; Bowen DM; Francis PT; Neary D Neuroscience; 1990; 38(3):571-7. PubMed ID: 1980143 [TBL] [Abstract][Full Text] [Related]
71. Animal models of Alzheimer's disease: glutamatergic denervation as an alternative approach to cholinergic denervation. Myhrer T Neurosci Biobehav Rev; 1993; 17(2):195-202. PubMed ID: 8515902 [TBL] [Abstract][Full Text] [Related]
72. Neurochemical alterations in Rett syndrome. Wenk GL; O'Leary M; Nemeroff CB; Bissette G; Moser H; Naidu S Brain Res Dev Brain Res; 1993 Jul; 74(1):67-72. PubMed ID: 8403377 [TBL] [Abstract][Full Text] [Related]
73. Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. Procter AW; Palmer AM; Francis PT; Lowe SL; Neary D; Murphy E; Doshi R; Bowen DM J Neurochem; 1988 Mar; 50(3):790-802. PubMed ID: 3339353 [TBL] [Abstract][Full Text] [Related]
76. Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells? Hertz L Brain Res Brain Res Rev; 1989; 14(4):335-53. PubMed ID: 2696574 [TBL] [Abstract][Full Text] [Related]